CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ·Healthcare·Biotechnology
$3.50
-1.41%
Mkt Cap $4.54M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$12.50
Range $11.00 – $14.00
Implied Upside
+257.1%
Consensus $12.50 vs current $3.50
NASDAQ·Healthcare·Biotechnology
$3.50
-1.41%
Mkt Cap $4.54M
No recent rating data.
Price Target (2 analysts)
$12.50
Range $11.00 – $14.00
+257.1%
Consensus $12.50 vs current $3.50